Orbitomaxillofacial Mucormycosis Requiring Complex Multifactorial Management
- PMID: 30534490
- PMCID: PMC6250482
- DOI: 10.1097/GOX.0000000000001927
Orbitomaxillofacial Mucormycosis Requiring Complex Multifactorial Management
Abstract
Mucormycosis is a rare fungal infection caused by ubiquitous fungi in the order Mucorales. It is the most rapidly progressing fulminant fungal infection that mimics necrotizing soft-tissue infections. Overwhelming fungal sepsis develops quickly and mortality rates approach 70%. Culture negative necrotizing infections and cutaneous necrosis following a vascular pattern should raise suspicion for this rare entity. We describe avoiding mortality in a case of orbitomaxillofacial mucormycosis multifactorially treated with: radical serial debridement, topical amphotericin B irrigation and dressings, parenteral amphotericin B, and hyperbaric oxygen therapy. Tissue biopsy was central to confirming the diagnosis and directing multimodal management that ultimately prevented dissemination to the central nervous system and mortality.
Figures
References
-
- Losee JE, Selber J, Vega S, et al. Primary cutaneous mucormycosis: guide to surgical management. Ann Plast Surg. 2002;49:385. - PubMed
-
- Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10:31. - PubMed
-
- Ryan ME, Ochs D, Ochs J. Primary cutaneous mucormycosis: superficial and gangrenous infections. Pediatr Infect Dis. 1982;1:110. - PubMed
-
- Bentur Y, Shupak A, Ramon Y, et al. Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus. Plast Reconstr Surg. 1998;102:822. - PubMed
-
- Cohen-Ludmann C, Kerob D, Feuilhade M, et al. Zygomycosis of the penis due to Rhizopus oryzae successfully treated with surgical debridement and a combination of high-dose liposomal and topical amphotericin B. Arch Dermatol. 2006;142:1657. - PubMed
Publication types
LinkOut - more resources
Full Text Sources